Target and Mechanism Trends GLP-1 remains the dominant target in obesity drug development, thanks to its proven efficacy and safety record
Whether you're looking to reduce fine lines and wrinkles, fade hyperpigmentation, or accelerate the healing of skin injuries, GHK-Cu has the potential to transform your complexion and restore your skin's youthful glow
Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing This post was updated on March 27, 2024 to include a clarification of the drugs included in the analysis and additional information about rebates
Sodium challenge does not support an acute gastrointestinal-renal natriuretic signaling axis in humans
Multi-receptor binding requires precise molecular geometry, and maintaining binding affinity across two or three receptor targets while also achieving oral bioavailability, metabolic stability, and acceptable safety constrains the chemical design space enormously